Partnership Opportunities

Showcase Your Brand to the Leading Minds of HFpEF & HCM Drug Discovery & Development

Partnering with the 2nd HFpEF & HCM Drug Discovery & Development Summit is a proven way to attract the attention of key decision makers and aid their strategies at a critical time.

This is your opportunity to influence future partnering opportunities and ensure companies know of your capabilities.

We’ll work with you to build a bespoke partnership package focused on making valuable connections and generating actionable leads to ensure you meet your 2023 commercial objectives in this overdue in-person reality.

Don’t miss this unique opportunity to demonstrate your technological experience and thought leadership to meet the increasing demands of this fast-growing field!

Who Attends?

Who will you meet

Current Partners:

AnaBios logo
Antaros Medical AB
MyData-Trust
Novoheart_Logo
OM1_Logo
logo-physiogenex
Nordic-Bioscience

Experts Need Your Help With:

  • Evaluating drugs targeting metabolic disorders, fibrosis or cardiovascular complications
  • Developing gene therapy approaches for inherited heart diseases
  • Assessing clinical trial outcomes by measuring cardiac output
    And more!

 

Why Partner?

UTILIZE your valuable time and resources by learning how the leading companies in the space are advancing successful clinical trials for specific HFpEF & HCM drug development

INTEGRATE your understanding of the mechanisms driving HFpEF and identifying novel targets to shape new research in heart failure with preserved ejection fraction and rare cardiomyopathies

BUILD new and strengthen existing connections with key thought leaders to advise and steer your pipeline’s acceleration